Hopefully they can clarify their competitive position. It seems that antibody drugs have superior efficacy, and may well be on the market sooner.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025